Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage
暂无分享,去创建一个
M. Barbe | M. Rico | M. Amin | C. Barrero | Oscar Perez-Leal | M. Florez | Dennis J. Colussi | Victor Olusajo | Dennise S. Rios
[1] Q. Geng,et al. HDAC3 promotes macrophage pyroptosis via regulating histone deacetylation in acute lung injury , 2023, iScience.
[2] C. Hermenegildo,et al. Extracellular Histones Activate Endothelial NLRP3 Inflammasome and are Associated with a Severe Sepsis Phenotype , 2022, Journal of inflammation research.
[3] Wenxin Wang,et al. Role of Histone Post-Translational Modifications in Inflammatory Diseases , 2022, Frontiers in Immunology.
[4] Merav D Shmueli,et al. Histone degradation by the proteasome regulates chromatin and cellular plasticity , 2021, The FEBS journal.
[5] F. Martinez,et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease , 2020, American journal of respiratory and critical care medicine.
[6] A. Birukova,et al. Extracellular histones in lung dysfunction: a new biomarker and therapeutic target? , 2020, Pulmonary circulation.
[7] S. De Flora,et al. Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung , 2020, Scientific Reports.
[8] A. Bonev,et al. Extracellular histones induce calcium signals in the endothelium of resistance-sized mesenteric arteries and cause loss of endothelium-dependent dilation. , 2019, American journal of physiology. Heart and circulatory physiology.
[9] G. Criner,et al. Chronic Obstructive Pulmonary Disease: Evaluation and Management. , 2019, The Medical clinics of North America.
[10] Wei Huang,et al. Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders , 2018, Journal of cellular and molecular medicine.
[11] E. Evangelou,et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis , 2018, International journal of chronic obstructive pulmonary disease.
[12] P. Jiang,et al. Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome , 2017, Respiratory Research.
[13] I. Rahman,et al. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[14] S. Zeerleder,et al. Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation , 2016, Cell Death & Disease.
[15] K. Hartshorn,et al. Histones as mediators of host defense, inflammation and thrombosis. , 2016, Future microbiology.
[16] F. Mohamed,et al. The extensor carpi ulnaris pseudolesion: evaluation with microCT, histology, and MRI , 2015, Skeletal Radiology.
[17] Jovilė Raudoniūtė,et al. Novel aspects of pathogenesis and regeneration mechanisms in COPD , 2015, International journal of chronic obstructive pulmonary disease.
[18] E. Ford. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. , 2015, Chest.
[19] D. Tang,et al. Release and activity of histone in diseases , 2014, Cell Death and Disease.
[20] H. Anders,et al. Extracellular histones in tissue injury and inflammation , 2014, Journal of Molecular Medicine.
[21] I. Rahman,et al. Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer. , 2014, Journal of proteome research.
[22] Oscar Perez-Leal,et al. Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[23] P. Bray,et al. Erosive Arthritis and Hepatic Granuloma Formation Induced by Peptidoglycan Polysaccharide in Rats Is Aggravated by Prasugrel Treatment , 2013, PloS one.
[24] Yie Yang,et al. Expression level of histone deacetylase 2 correlates with occurring of chronic obstructive pulmonary diseases , 2013, Molecular Biology Reports.
[25] V. Kim,et al. Chronic bronchitis and chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[26] N. Zhang,et al. Circulating histones are mediators of trauma-associated lung injury. , 2013, American journal of respiratory and critical care medicine.
[27] M. Rico,et al. Prasugrel Metabolites Inhibit Neutrophil Functions , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[28] Deepti Malhotra,et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. , 2009, American journal of respiratory and critical care medicine.
[29] P. Barnes. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.
[30] Jun Xu,et al. Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.
[31] P. Barnes. Histone deacetylase-2 and airway disease , 2009, Therapeutic advances in respiratory disease.
[32] A. Gunjan,et al. Histone levels are regulated by phosphorylation and ubiquitylation dependent proteolysis , 2009, Nature Cell Biology.
[33] P. Barnes,et al. Role of HDAC2 in the pathophysiology of COPD. , 2009, Annual review of physiology.
[34] Hongwei Yao,et al. Current Perspectives on Role of Chromatin Modifications and Deacetylases in Lung Inflammation in COPD , 2009, COPD.
[35] P. Barnes. Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic , 2007, PLoS medicine.
[36] I. Sainz,et al. Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1‐derived peptide treatment , 2007, Journal of cellular physiology.
[37] D. Tang,et al. Apoptotic Release of Histones from Nucleosomes* , 2002, The Journal of Biological Chemistry.
[38] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[39] C Hermans,et al. Lung epithelium-specific proteins: characteristics and potential applications as markers. , 1999, American journal of respiratory and critical care medicine.
[40] J. Zlatanova,et al. Cytoplasmic pool of histone H1 in mammalian cells. , 1990, Journal of cell science.
[41] R. Crystal,et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.
[42] E. Ford,et al. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. , 2015, Chest.
[43] M. Duerden. Prevention of death in COPD. , 2007, The New England journal of medicine.